Warnex to Distribute Gendia's Tests in Canada | GenomeWeb
NEW YORK (GenomeWeb News) – Quebec-based bioanalytical company Warnex said today that it has agreed to become the exclusive distributor of molecular diagnostic tests for the Gendia network in Canada.
Gendia is an international lab testing network with over 50 labs in the US, Europe, and Australia, and it offers more than 2,000 different genetic tests. Its goal is to provide and improve access, cost effectiveness, and quality for diagnostic tests for rare genetic disorders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.